Acute myeloblastic leukemia in AIDS. AIDS 1990; 4:367–8. , , , , .
The lineage decisions of helper T cells. Nat Rev Immunol 2002; 2:933–44. , .
et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 2005; 6:1133–41. , ,
Comparison of IL-17 production by helper T cells among atopic and nonatopic asthmatics and control subjects. Int Arch Allergy Immunol 2005; 137 (Suppl. 1):51–4. , , , .
et al. Double-blind randomized controlled clinical trial of the interleukin-6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexate. Arthritis Rheum 2006; 54:2817–29. , ,
Absence of regulatory T-cell control of TH1 and TH17 cells is responsible for the autoimmune-mediated pathology in chronic graft-versus-host disease. Blood 2007; 110:3804–13. , , , , , .
et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006; 441:235–8. , ,
et al. Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 2006; 441:231–4. , ,
TG F-beta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 2006; 24:179–89. , , , , .
et al. The orphan nuclear receptor ROR gamma t directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 2006; 126:1121–33. , ,
Th17 cell differentiation: the long and winding road. Immunity 2008; 28:445–53. , .
et al. A critical function for transforming growth factor-beta, interleukin 23 and proinflammatory cytokines in driving and modulating human T(H)-17 responses. Nat Immunol 2008; 9:650–7. , ,
Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells. Nat Immunol 2007; 8:942–9. , , , .
et al. Effector memory T cells, early metastasis, and survival in colorectal cancer. N Engl J Med 2005; 353:2654–66. , ,
T-bet regulates metastasis rate in a murine model of primary prostate cancer. Cancer Res 2004; 64:452–5. , , , , .
Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma. Cancer Res 2005; 65:2457–64. , , , , , .
Intratumoral CD4+CD25+ regulatory T cell-mediated suppression of infiltrating CD4+T cells in B cell non-Hodgkin lymphoma. Blood 2006; 107:3639–46. , , , , .
et al. Increased population of CD4(+)CD25(high), regulatory T cells with their higher apoptotic and proliferating status in peripheral blood of acute myeloid leukemia patients. Eur J Haematol 2005; 75:468–76. , ,
et al. Cutting edge: Th17 and regulatory T cell dynamics and the regulation by IL-2 in the tumor microenvironment. J Immunol 2007; 178:6730–3. , ,
et al. The prevalence of Th17 cells in patients with gastric cancer. Biochem Biophys Res Commun 2008; 374:533–7. , ,
Drug therapy for acute myeloid leukemia. Blood 2005; 106:1154–63. , , .
et al. Proposals for the classification of the acute leukaemias. French–American–British (FAB) Co-operative Group. Br J Haematol 1976; 33:451–8. , ,
et al. Proposed revised criteria for the classification of acute myeloid leukaemia. A report of the French–American–British Cooperative Group. Ann Intern Med 1985; 103:620–5. , ,
et al. Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia. J Clin Oncol 1990; 8:813–19. , ,
Internalization, lysosomal degradation and new synthesis of surface membrane CD4 in phorbol ester-activated T-lymphocytes and U-937 cells. Exp Cell Res 1992; 201:160–73. , , , .
Intracellular cytokine repertoire in different T cell subsets from patients with sarcoidosis. Thorax 2001; 56:487–93. , , , , , .
et al. Species differences in the effect of pregnancy on lymphocyte cytokine production between human and rat. J Leukoc Biol 2005; 78:946–53. , ,
Interleukin-17 in acute myeloid leukemia. J Cell Mol Med 2003; 7:472–4. , , , .
et al. Interleukin-17 promotes angiogenesis and tumor growth. Blood 2003; 101:2620–7. , ,
et al. IL-17 enhances the net angiogenic activity and in vivo growth of human non-small cell lung cancer in SCID mice through promoting CXCR-2-dependent angiogenesis. J Immunol 2005; 175:6177–89. , ,
et al. Tumor-specific Th17-polarized cells eradicate large established melanoma. Blood 2008; 112:362–73. , ,
et al. Prognostic significance of tumor burden in the blood of patients with erythrodermic primary cutaneous T-cell lymphoma. Blood 2001; 97:624–30. , ,
et al. Development, cytokine profile and function of human interleukin17-producing helper T cells. Nat Immunol 2007; 8:950–7. , ,
Distinct regulation of interleukin-17 in human T helper lymphocytes. Arthritis Rheum 2007; 56:2936–46. , , , , .
et al. IL-21 and TGF-beta are required for differentiation of human T(H)17 cells. Nature 2008; 454:350–2. , ,
The differentiation of human T(H)-17 cells requires transforming growth factor-beta and induction of the nuclear receptor RORgammat. Nat Immunol 2008; 9:641–9. , , .